Role of pharmacists to be extended
April 4, 2008Pharmacists are to be given a greater role in patient treatment and promoting good health under new government plans. The …
Make Alzheimer’s a top research priority, says public
April 1, 2008The British public wants a greater focus on research into Alzheimer's disease, according to an opinion poll conducted by the …
UCB’s Cimzia fails to appeal to European regulators
April 1, 2008Sales and Marketing EU
UCB's Crohn's disease drug Cimzia has been denied European approval for a second time after regulators said lacked sufficient evidence …
Latest news from Datamonitor
March 31, 2008Sales and Marketing
The impact of the US presidential race on healthcare IT The three leaders in the race for the US presidency; …
The role of audit in marketing excellence
March 28, 2008Sales and Marketing audit, excellence, marketing
The goal for any business leader, whether they run a company, business unit or brand, should always be 100% alignment …
Gardasil licence extension gets priority FDA review
March 28, 2008Sales and Marketing
Merck has received priority review status from the FDA for its application to extend the licence of its cervical cancer …
Accomplia gains limited NICE approval
March 28, 2008Sales and Marketing
Sanofi-Aventis' weight-loss pill Acomplia has been approved for prescription on the NHS, but only for patients who fail to respond …
Merck’s hepatitis B vaccine trial on hold
March 28, 2008Sales and Marketing
US regulators have placed a 'clinical hold' on one of the trials for Merck's hepatitis B vaccine Heplisav, raising questions …
Boehringer Ingelheim’s Pradaxa approved in Europe
March 28, 2008Sales and Marketing
European regulators have approved Boehringer Ingelheim's novel anti-clotting pill Pradaxa, paving the way it to be launched in the coming …
Pharming’s orphan drug receives second setback in Europe
March 26, 2008Sales and Marketing HAE, Pharming
Dutch biotech company Pharming has suffered a blow, after its lead product Rhucin was rejected by European regulators for a …
NHS Trusts to promote their services to the public
March 25, 2008Medical Communications
All patients needing routine hospital care will soon be able to choose from any approved NHS trust in the country. …
Latest news from Datamonitor
March 25, 2008Sales and Marketing em
Faced with dwindling growth rates in the US and Europe, drug companies are turning their attention towards emerging pharmaceutical markets …
Early access to experimental drugs for terminally ill
March 25, 2008Sales and Marketing
Terminally ill cancer patients are to get early access to developmental drugs in a bid to halve the time it …
GSK consolidates Cervarix PR ahead of crucial vaccine decision
March 25, 2008Medical Communications
GlaxoSmithKline has reorganised the PR support for its cervical cancer vaccine Cervarix, choosing just one agency to handle the UK …
Latest news from Datamonitor
March 20, 2008Sales and Marketing
With pharmaceutical companies struggling to maintain pipelines and portfolios with products developed in-house, organizations are increasingly turning to licensing to …
Onwards and upwards
March 20, 2008Business Services career, planning, recruitment
In an era of elusive blockbusters, job cuts and growing insecurity in the pharma industry, the skills you need to …
AZ and Silence to collaborate on gene technology
March 20, 2008Research and Development
AstraZeneca has signed a deal with UK biotech firm Silence Therapeutics to develop a range of novel approaches for the …
Nexium and Seroquel face US generic fight
March 20, 2008Sales and Marketing
AstraZeneca is to face a crucial court battle over one of its biggest brands, Seroquel. Generics companies Teva and Sandoz …
Manchester selected for translational medicine centre
March 19, 2008Research and Development
A new Biomedical Research Centre of excellence is to be created in Manchester to help the UK bridge the gap …
Side-effect caution to delay Tyverb
March 19, 2008Research and Development
GlaxoSmithKline has informed regulators in the US and Europe that a small number of patients taking its new breast cancer …
